Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

88.8K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.4K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

513
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
513
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

503
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-chain fructooligosaccharides protect against intestinal injury in NEC by restoring AKT/GSK-3β signaling.

Journal of pediatric surgery·2026
Same author

Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn's Disease in First-degree Relatives.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Omega-3 polyunsaturated fatty acids and the eicosapentaenoic acid metabolite 18-hydroxyeicosapentaenoic acid (18-HEPE) attenuate experimental necrotizing enterocolitis.

Clinical nutrition (Edinburgh, Scotland)·2025
Same author

Abundance of <i>Bifidobacterium</i> species in the infant gut microbiota and associations with maternal-infant characteristics in Dhaka, Bangladesh.

mSphere·2025
Same author

Neonatal administration of <i>Lactiplantibacillus plantarum</i> ATCC 202195 with or without fructooligosaccharide in Bangladesh: a placebo-controlled randomized trial.

mSphere·2025
Same author

Mother's milk microbiota is associated with the developing gut microbial consortia in very-low-birth-weight infants.

Cell reports. Medicine·2024

Related Experiment Video

Updated: Mar 5, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management.

Thomas R Abrahamsson, Richard Y Wu, Philip M Sherman

    Nestle Nutrition Institute Workshop Series
    |March 28, 2017
    PubMed
    Summary

    Probiotics, live beneficial microbes, can restore gut health and treat conditions like infant colic and irritable bowel syndrome. Their effectiveness depends on specific strains and optimal timing for intervention.

    More Related Videos

    Probiotic Studies in Neonatal Mice Using Gavage
    10:36

    Probiotic Studies in Neonatal Mice Using Gavage

    Published on: January 27, 2019

    21.0K
    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
    11:22

    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

    Published on: October 15, 2019

    31.4K

    Related Experiment Videos

    Last Updated: Mar 5, 2026

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
    05:41

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

    Published on: April 6, 2022

    3.5K
    Probiotic Studies in Neonatal Mice Using Gavage
    10:36

    Probiotic Studies in Neonatal Mice Using Gavage

    Published on: January 27, 2019

    21.0K
    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
    11:22

    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

    Published on: October 15, 2019

    31.4K

    Area of Science:

    • Gastroenterology
    • Microbiology
    • Immunology

    Background:

    • The intestinal microbiome plays a crucial role in human health.
    • Dysbiosis, an altered gut microflora, is linked to functional gastrointestinal disorders like colic and irritable bowel syndrome.
    • Probiotics are live microorganisms that confer health benefits by restoring microbial balance.

    Purpose of the Study:

    • To review the efficacy of probiotics in managing intestinal conditions.
    • To explore the mechanisms underlying probiotic effects.
    • To identify future directions for probiotic research and application.

    Main Methods:

    • Review of randomized controlled trials on probiotic interventions.
    • Analysis of strain-specific effects on gut physiology and immunity.
    • Discussion of current research on probiotic mechanisms.

    Main Results:

    • Probiotics demonstrate effectiveness in treating infant colic and irritable bowel syndrome.
    • Probiotic efficacy is influenced by factors such as strain specificity and intervention timing.
    • Mechanisms include promoting microbial diversity, enhancing barrier integrity, and modulating immune responses.

    Conclusions:

    • Probiotics offer a promising therapeutic strategy for various intestinal conditions.
    • Future probiotic use will likely be guided by specific mechanisms of action.
    • Further research is needed to optimize dosage, formulation, and delivery of probiotics.